Research programme: kinesin spindle protein inhibitors - Array BioPharma

Drug Profile

Research programme: kinesin spindle protein inhibitors - Array BioPharma

Alternative Names: ARRY-649; KSP inhibitors - Array BioPharma

Latest Information Update: 12 Aug 2011

Price : $50

At a glance

  • Originator Array BioPharma
  • Class
  • Mechanism of Action KIF11 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 12 Aug 2011 No development reported - Preclinical for Cancer in USA (PO)
  • 12 Aug 2011 No development reported - Preclinical for Cancer in USA (IV)
  • 01 May 2006 Preclinical trials in Cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top